Enhanced Expression of T-Cell Activation and Natural Killer Cell Antigens Indicates Systemic Anti-Tumor Response in Early Primary Cutaneous T-Cell Lymphoma

This publication has 20 references indexed in Scilit:

• Progression of Mycosis Fungoides Is Associated with Increasing Cutaneous Expression of Interleukin-10 mRNA
  Journal of Investigative Dermatology, 1996
• Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas
  Archives of Dermatological Research, 1996
• Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma ? the D sseldorf and Munich experience
  Archives of Dermatological Research, 1995
• Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.
  The Journal of Experimental Medicine, 1994
• Selective activation of circulating CD4+ lymphocytes in severe adult atopic dermatitis
  British Journal of Dermatology, 1992
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
  The Journal of Experimental Medicine, 1991
• T-Cell Subsets with a Naive Phenotype are Selectively Decreased in the Peripheral Blood of Patients with Mycosis Fungoides
  Journal of Investigative Dermatology, 1991
• in vivo effects of combination treatment with recombinant interferon‐gamma and ‐alpha in metastatic melanoma
  International Journal of Cancer, 1989
• Clonal anergy induced in mature Vβ6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells
  Nature, 1989
• Prospective Staging Evaluation of Patients with Cutaneous T-Cell Lymphomas
  Annals of Internal Medicine, 1980